Revolutionizing trauma care: advancing coagulation management and damage control anesthesia.

Area of Science:

• Trauma Medicine
• Immunology
• Anesthesiology

Background:

• Massive hemorrhage remains a leading cause of preventable trauma deaths.
• Trauma-induced coagulopathy involves complex immunological mechanisms like endotheliopathy and glycocalyx shedding.
• Factors such as acidosis, hypothermia, and anticoagulant use worsen coagulopathy.

Purpose of the Study:

• To introduce a damage-control anesthetic management strategy for trauma patients.
• To integrate recent advances in damage-control resuscitation and coagulopathy research.
• To discuss brain-protective strategies and viscoelastic assay utilization in trauma care.

Main Methods:

• Review of immunological mechanisms in early trauma.
• Application of damage-control resuscitation principles to anesthetic management.
• Integration of rapid transport, bleeding control, and early product administration.
• Discussion of brain protection and viscoelastic monitoring.

Main Results:

• Elucidation of key mechanisms in trauma-induced coagulopathy.
• Emphasis on early antifibrinolytic and fibrinogen concentrate administration.
• Highlighting the importance of maintaining calcium levels and body temperature.
• Introduction of viscoelastic assays for goal-directed coagulation management.

Conclusions:

• Damage-control anesthetic management offers a comprehensive approach to trauma care.
• Early intervention and targeted therapies are crucial for managing massive hemorrhage.
• This strategy may improve outcomes for trauma patients, particularly those with brain injuries.